1. Home
  2. AZTR vs SNTG Comparison

AZTR vs SNTG Comparison

Compare AZTR & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • SNTG
  • Stock Information
  • Founded
  • AZTR 2014
  • SNTG 2009
  • Country
  • AZTR United States
  • SNTG China
  • Employees
  • AZTR N/A
  • SNTG N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • SNTG Finance: Consumer Services
  • Sector
  • AZTR Health Care
  • SNTG Finance
  • Exchange
  • AZTR Nasdaq
  • SNTG Nasdaq
  • Market Cap
  • AZTR 4.0M
  • SNTG 4.8M
  • IPO Year
  • AZTR 2023
  • SNTG 2021
  • Fundamental
  • Price
  • AZTR $0.22
  • SNTG $1.94
  • Analyst Decision
  • AZTR
  • SNTG
  • Analyst Count
  • AZTR 0
  • SNTG 0
  • Target Price
  • AZTR N/A
  • SNTG N/A
  • AVG Volume (30 Days)
  • AZTR 798.9K
  • SNTG 7.3K
  • Earning Date
  • AZTR 08-11-2025
  • SNTG 08-05-2025
  • Dividend Yield
  • AZTR N/A
  • SNTG N/A
  • EPS Growth
  • AZTR N/A
  • SNTG N/A
  • EPS
  • AZTR N/A
  • SNTG N/A
  • Revenue
  • AZTR $7,500.00
  • SNTG $107,507.00
  • Revenue This Year
  • AZTR N/A
  • SNTG N/A
  • Revenue Next Year
  • AZTR N/A
  • SNTG N/A
  • P/E Ratio
  • AZTR N/A
  • SNTG N/A
  • Revenue Growth
  • AZTR N/A
  • SNTG N/A
  • 52 Week Low
  • AZTR $0.21
  • SNTG $1.43
  • 52 Week High
  • AZTR $1.25
  • SNTG $3.52
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 37.04
  • SNTG 53.90
  • Support Level
  • AZTR $0.22
  • SNTG $1.93
  • Resistance Level
  • AZTR $0.24
  • SNTG $1.96
  • Average True Range (ATR)
  • AZTR 0.01
  • SNTG 0.09
  • MACD
  • AZTR -0.00
  • SNTG -0.01
  • Stochastic Oscillator
  • AZTR 7.97
  • SNTG 30.36

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About SNTG Sentage Holdings Inc.

Sentage Holdings Inc is a financial service provider that offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.

Share on Social Networks: